Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article highlights the rising interest in Janus kinase inhibitors for alopecia areata, especially following the FDA approval of baricitinib, underscoring the need for better patient education and physician guidance in selecting appropriate treatments for hair loss.

This study observed that public interest in JAK-inhibitor treatments for alopecia areata significantly increased around the FDA approval in 2022 and heightened media coverage, suggesting an important role for patient education about these treatments.

This study found that TikTok videos about alopecia areata focusing on personal experiences, especially from women, were more engaging, while YouTube videos from healthcare providers rated higher in quality and accuracy.

This study found that patients using GLP-1 receptor agonists, specifically liraglutide, dulaglutide, and semaglutide, had a higher likelihood of being diagnosed with androgenetic alopecia, while those on exenatide showed increased odds for both androgenetic alopecia and telogen effluvium.

Hair transplant surgery successfully restored a woman's pubic hair, improving her appearance and satisfaction.

This article describes two cases where essential alopecia was the initial sign of syphilitic infection, examining the clinical and histopathologic features observed.

In this case report, tofacitinib led to significant improvement in arthritis and partial improvement in alopecia for a female patient with systemic lupus erythematosus, with no observed adverse effects.

This case report describes a transgender woman who achieved a soft, feminine hairline nine months post-hair transplant using follicles from both the occipital scalp and pubic area.

This study examined the current clinical practices for diagnosing and managing alopecia areata in Poland, finding that patient care is inadequate and falls short in using validated severity tools and providing access to advanced therapies despite the availability of new medications like Janus kinase inhibitors.

This study reports successful restoration of congenital pubic alopecia using tissue transfers from the temporoparietal scalp, noting significant hair growth in the transplanted tissue.

This review describes psychotropic drug-related hair loss as a possible but uncommon side effect, with resolution typically achieved by discontinuing the medication, and emphasizes clinician-patient discussions for managing the condition.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

In this study, Brazilian dermatologists reported that patients with alopecia areata, particularly those with severe scalp hair loss, often experience an unmet need for advanced therapies that could improve treatment outcomes beyond the limitations of current options.

In this study, young Ukrainian men with alopecia areata were found to have a "subpathological" body type, characterized by shorter lower limbs and longer upper limbs and torso compared to healthy peers.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

This article discusses the role of barbershops in public health education for skin disorders and suggests that educating barbers could help in early detection and prevention of some conditions; it reports no new experimental findings.

This study found significant gaps in knowledge, treatment awareness, and healthcare-seeking practices related to alopecia among the general population in Jazan, Saudi Arabia.

Alopecia areata significantly strains healthcare and finances in the UAE, needing better management.

Current evidence reviewed in this study indicates that finasteride, a drug for hair loss, can cause depression and suicidality, with delayed recognition partly due to insufficient post-approval pharmacovigilance by manufacturers and regulators.

This study found that using medical terminology for newly medicalized disorders leads people to perceive them as more serious, more representative of a disease, and less common than when common language is used.

This report describes a case of twins with alopecia areata totalis who did not respond to corticosteroids but showed significant hair growth with platelet rich plasma injections, suggesting PRP's potential as an alternative treatment.

This study describes the creation and two-year experience of a pioneering dermatological practice exclusively serving transgender and non-binary patients to address their unique dermatological concerns and promote healthcare equity, based on a retrospective analysis of 114 patients at a public hospital.

This study found that non-ablative and/or ablative fractional lasers promoted hair growth in patients with certain uncommon hair disorders, though effectiveness varied among different conditions.

This study suggests that acquired progressive kinking of hair, which typically appears at or after puberty, may be androgen dependent and could progress to male pattern baldness.

This article discusses the contributions of Dr. Shoji Okuda to the field of hair transplantation and reports no new research findings.

This article discusses the history of modern hair restoration surgery beginning with Dr. Norman Orentreich's introduction of the macrograft technique in 1959 and reports no new clinical results.

This case report describes a 14-year-old girl with signs of virilization, including increased facial and body hair, deepened voice, and elevated serum testosterone and androstenedione levels.

This study explains that congenital adrenal hyperplasia due to 21-hydroxylase deficiency presents as a continuous phenotype and involves symptoms ranging from virilization to accelerated growth in children, with diagnosis relying on clinical, biochemical, and genetic evaluation.

This study found that hair transplantation using micrografts and minigrafts achieved high patient satisfaction and a graft survival rate of about 90% for different types of hair loss.

This case describes a 14-year-old girl whose symptoms of hirsutism and virilization were attributed to an ovarian Sertoli-Leydig tumor, with improvement following surgical removal.